Carbon Dioxide Emission Reduction Scenarios in Mexico for Year 2005: Industrial Cogeneration and Efficient Lighting

An analysis of the impacts on Mexican energy demand and associated carbon dioxide (CO₂) emissions in the year 2005 due to efficient lighting in the commercial and residential sectors and cogeneration in the industrial sector is presented. Estimation of CO₂ abatement costs and an incremental cost curve for CO₂ mitigation options are considered. These technologies are cost effective opportunities, and together are projected to reduce CO₂ emissions in 2005 by nearly 13 percent. Implementation of efficient lighting is already part of the demand side management (DSM) programs of the Mexican state-owned utility. However, there are important barriers that may hinder the implementation of large scale cogeneration plants.     

Prenatal diagnosis of spinal muscular atrophy in Russia

Ninety-two families with spinal muscular atrophy (SMA) applied for genetic counselling and further prenatal diagnosis. To minimize expenses, only one tightly linked informative marker was determined in the course of preliminary examination, and non-radioactive allele detection was preferably used. Four prenatal diagnoses of SMA type I, four of SMA type II, and one of SMA type III were made. This trial programme shows the considerable requirements, importance, and potential effectiveness of prenatal prediction of SMA in Russia.     

The 48,XXYY syndrome: A case detected by maternal serum alpha-fetoprotein screening

A 17-year-old woman was referred for amniocentesis due to a low maternal serum alpha-fetoprotein (AFP) concentration in a voluntary screening test. The fetal karyotype was 48,XXYY, and the pregnancy was terminated. Autopsy of the fetus disclosed agenesis of the corpus callosum and unusual facial features.     

First-trimester prenatal diagnosis of aspartylglucosaminuria

Fetal aspartylglucosaminuria (AGU) was studied during the first trimester of pregnancy in six at-risk pregnancies using chorionic villus samples. The activity of aspartylglucosaminidase (AGA) was high in five cases, indicating an unaffected fetus. This was confirmed through delivery of healthy newborns with a normal pattern of urinary oligosaccharides. Low enzyme activity in an uncultured biopsy specimen and in cultured amniotic fluid cells in one case demonstrated that the fetus was affected. The pregnancy was terminated and the prenatal diagnosis was confirmed by showing reduced AGA activity in cultured fibroblasts of the fetus.